NMPA Accredited Essex’s Biologics License Utility for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Connected Macular Degeneration

HONG KONG, Aug 13, 2025 – (ACN Newswire) – Essex Bio-Technology Restricted (“Essex” or the “Community”, Inventory Code: 1061.HK) is joyful to screech that a Biologics License Utility (“BLA”) for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal antibody injection, has honest now now not too prolonged ago been licensed by the Centre for Drug Review (“CDE”) of the National Clinical Products Administration (“NMPA”) in China…
Read More